Weight Loss with Semaglutide

At RachelBWell, we want to help patients lose weight and keep it off for good! We provide weight loss treatment plans, with or without medication options. We are excited to offer compounded semaglutide for eligible patients, along with a flexible, holistic approach to weight loss.  Our program includes one-on-one appointments with a Nurse Practitioner to customize diet, modify exercise, and optimize lifestyle behaviors to meet the unique needs of our patients. 

12 Week Weight Loss Package

We know the weight loss process can feel overwhelming, but we are here to help you every step of the way! 

Our 12-week weight loss package includes:

  • 3 in person appointments
  • 2 virtual check-in appointments
  • Body composition analysis before and during treatment
  • Customized Nutrition and Lifestyle Counseling
  • Supplement recommendations to enhance weight loss and blood sugar regulation. 
  • RachelBWell Cookbook with delicious, easy, recipes designed to battle hormonal weight gain 

Nonrefundable $175 initial consultation. If a patient is found eligible for medication treatment, the initial $175 fee goes towards the total cost of 12-week program treatment of $1389.

Schedule your consultation appointment, today!

What is Semaglutide?

Semaglutide is a drug in the class of medications called GLP-1 Agonists (glucagon-like peptide agonist) that has been approved by the FDA for use in people with diabetes for over 15 years. Recently, this medication has been approved for the treatment of obesity.

How does Semaglutide work?

Semaglutide imitates the hormone GLP-1, which stimulates another hormone called incretin to be secreted in the body. Incretin is responsible for regulating the hormone   insulin. Insulin helps to control blood sugar by carrying sugar from the bloodstream into the cells of the body so that it can be used effectively as energy. Normal insulin levels are essential for optimal blood sugar regulation and successful weight loss.  

Semaglutide also decreases appetite and causes delayed gastric emptying. This delayed emptying  means food stays in the stomach for longer, resulting in feeling fuller for a longer period of time.  This medication can be very helpful for patients who have  struggled to weight in the past and failed or who struggle with unregulated blood sugars.

Studies have shown that Semaglutide can reduce the risk of heart disease (Melillo, 2020), heart attack and stroke (Melillo, 2020), lower blood pressure (Melillo, 2020), improve mobility, prevent osteoarthritis (Windsor, 2021), prevent sleep apnea (Windsor, 2021), and can be an effective treatment for Polycystic Ovarian Syndrome (PCOS) (Cena and Nappi, 2020).

* Physical exam and bloodwork are required at first appointment to determine patient eligibility.


Cena, H., Chiovato, L., & Nappi, R. E. (2020, August 1). Obesity, polycystic ovary syndrome, and infertility: A new avenue for GLP-1 receptor agonists. The Journal of clinical endocrinology and metabolism. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457958/

Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., & Wharton, S. (2022, October 10). Two-year effects of semaglutide in adults with overweight or obesity: The step 5 trial. Nature News. https://www.nature.com/articles/s41591-022-02026-4

Ghusn, W. (2022, September 19). Weight loss outcomes and SEMAGLUTIDE treatment for patients with overweight or obesity. JAMA Network Open. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796491

Melillo, G. (2020, July 30). SEMAGLUTIDE approved for cardiovascular risk reduction in adults with T2D. AJMC. https://www.ajmc.com/view/semaglutide-approved-for-cardiovascular-risk-reduction-in-adults-with-t2dWindsor, M. (2021, April 9). Who will benefit from new “game-changing” weight-loss drug semaglutide? The University of Alabama at Birmingham News. https://www.uab.edu/news/research/item/11961-who-will-benefit-from-new-game-changing-weight-loss-drug-semaglutide